What is the likely cause and recommended management of tongue ulcers in a patient taking lamotrigine, lurasidone (Latuda), paroxetine, and benztropine?

Tongue Sores in Patient on Lamotrigine, Latuda, Paroxetine, and Benztropine

Lamotrigine is the most likely culprit for tongue ulcers in this patient and should be discontinued immediately after consultation with the prescribing physician, as these lesions may represent early signs of serious hypersensitivity reactions.

Primary Concern: Lamotrigine-Induced Oral Ulceration

Lamotrigine carries significant risk for oral mucosal injury, including potentially serious hypersensitivity reactions. The medication can cause oral ulcers that appear weeks after dose stabilization or after discontinuation of enzyme-inducing drugs 1. These ulcers are often painful, resist conventional treatments, and resolve rapidly after drug withdrawal 2. More concerning, oral lesions may represent early manifestations of severe cutaneous adverse reactions 3.

Critical Action Steps:

1. Immediate assessment: Examine for accompanying symptoms including fever, facial swelling, lymphadenopathy, or other mucocutaneous involvement that could indicate Stevens-Johnson syndrome/toxic epidermal necrolysis
2. Urgent consultation: Contact the prescribing psychiatrist immediately to discuss lamotrigine discontinuation
3. Do not rechallenge: Once lamotrigine-induced oral ulcers occur, the drug should not be restarted

Secondary Consideration: Paroxetine

Paroxetine (SSRI) has documented association with oral ulcerations and black hairy tongue 4, 5. A recent case demonstrated recurrent palatal ulcerations and brown hairy tongue that markedly improved following paroxetine withdrawal 4. Large-scale pharmacovigilance data confirms SSRIs, including paroxetine, generate significant signals for oral ulcer risk 5.

Lower Probability: Lurasidone (Latuda)

While Latuda's FDA label does not specifically list oral ulcers as a common adverse effect 6, atypical antipsychotics as a class can cause oral complications. However, this is less likely than lamotrigine or paroxetine as the causative agent.

Benztropine: Unlikely Direct Cause

Benztropine (anticholinergic) typically causes dry mouth rather than ulcerations, though xerostomia can secondarily predispose to oral lesions through reduced salivary protection.

Management Algorithm

Step 1: Immediate Evaluation

• Document ulcer location, size, appearance (well-demarcated with pseudomembrane suggests drug reaction)
• Check for systemic symptoms (fever, rash, malaise)
• Assess tongue appearance for hairy tongue or discoloration
• Rule out infectious causes with oral swabs if indicated 7

Step 2: Symptomatic Treatment 8, 9

• Apply white soft paraffin to affected areas
• Benzydamine hydrochloride spray every 3 hours, especially before eating
• Viscous lidocaine 2% for severe pain
• Dexamethasone mouth rinse (0.1 mg/mL) or clobetasol gel 0.05% for localized ulcers
• Maintain oral hygiene with bland sodium bicarbonate mouthwash 4-6 times daily 9

Step 3: Drug Modification

• Primary action: Discontinue lamotrigine after psychiatric consultation (most likely cause given temporal relationship and documented association)
• If ulcers persist after lamotrigine cessation: Consider paroxetine as secondary culprit and discuss alternative antidepressant with prescriber
• Monitor for improvement over 4-7 days after drug withdrawal 2

Step 4: Follow-up

• Ulcers should begin healing within days of stopping the offending agent
• If no improvement within 1 week or worsening occurs, consider biopsy to rule out other pathology 7
• Ensure psychiatric stability is maintained with alternative medications

Critical Pitfalls to Avoid

• Do not assume traumatic etiology without considering drug causes in polypharmacy patients
• Do not delay lamotrigine discontinuation if serious hypersensitivity is suspected—this can progress to life-threatening conditions
• Do not restart lamotrigine once oral ulcers have occurred, as rechallenge carries significant risk 1
• Do not overlook drug interactions: If this patient was recently tapered off any enzyme-inducing medications, lamotrigine levels may have gradually increased over weeks, precipitating toxicity 1

Drug Interaction Consideration

The combination of these medications does not create obvious pharmacokinetic interactions that would elevate lamotrigine levels. However, if the patient recently discontinued any enzyme-inducing anticonvulsants (not mentioned but worth investigating), lamotrigine levels could have slowly risen over several weeks, manifesting as delayed oral toxicity 1.